These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Chiu CT; Chuang DM Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090 [TBL] [Abstract][Full Text] [Related]
69. Management of tardive dyskinesia: current update. Simpson GM; Pi EH; Sramek JJ Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137 [TBL] [Abstract][Full Text] [Related]
70. Intra-patient variability in the measurement of tardive dyskinesia. Richardson MA; Craig TJ; Branchey MH Psychopharmacology (Berl); 1982; 76(3):269-72. PubMed ID: 6808548 [TBL] [Abstract][Full Text] [Related]
71. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain. Reches A; Jackson-Lewis V; Fahn S Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824 [TBL] [Abstract][Full Text] [Related]
72. What's new in the psychopharmacology of schizophrenia. Rifkin A; Quitkin F Bull N Y Acad Med; 1978 Oct; 54(9):869-78. PubMed ID: 280396 [No Abstract] [Full Text] [Related]
73. A rating scale for tardive dyskinesia. Simpson GM; Lee JH; Zoubok B; Gardos G Psychopharmacology (Berl); 1979 Aug; 64(2):171-9. PubMed ID: 115037 [TBL] [Abstract][Full Text] [Related]
74. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial. Gerlach J; Thorsen K; Munkvad I Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002 [TBL] [Abstract][Full Text] [Related]
75. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study. Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975 [TBL] [Abstract][Full Text] [Related]
76. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics]. Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663 [TBL] [Abstract][Full Text] [Related]
77. [Tardive dyskinesia induced by neuroleptics. A review of the literature]. Diepart E; Cottereau MJ; Deniker P Encephale; 1979; 5(4):317-37. PubMed ID: 42528 [TBL] [Abstract][Full Text] [Related]
78. Lithium carbonate in the treatment of movement disorders. A critical review. Yassa R; Ananth J Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936 [TBL] [Abstract][Full Text] [Related]
79. Lithium in tardive dyskinesia. Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411 [TBL] [Abstract][Full Text] [Related]